The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials

Heinz Drexel; Giuseppe M C Rosano; Basil S Lewis; Kurt Huber; Alexander Vonbank; Jörn F Dopheide; Arthur Mader; Alexander Niessner; Gianluigi Savarese; Sven Wassmann; Stefan Agewall

doi:10.1093/ehjcvp/pvz029

The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials

Heinz Drexel, Giuseppe M C Rosano, Basil S Lewis, Kurt Huber, Alexander Vonbank, Jörn F Dopheide, Arthur Mader, Alexander Niessner, Gianluigi Savarese, Sven Wassmann, Stefan Agewall

IRCCS San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European heart journal. Cardiovascular pharmacotherapy
DOIs	https://doi.org/10.1093/ehjcvp/pvz029
Publication status	E-pub ahead of print - Jul 12 2019

Access to Document

10.1093/ehjcvp/pvz029

Cite this

Drexel, H., Rosano, G. M. C., Lewis, B. S., Huber, K., Vonbank, A., Dopheide, J. F., Mader, A., Niessner, A., Savarese, G., Wassmann, S., & Agewall, S. (2019). The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials. European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvz029

The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials. / Drexel, Heinz; Rosano, Giuseppe M C; Lewis, Basil S; Huber, Kurt; Vonbank, Alexander; Dopheide, Jörn F; Mader, Arthur; Niessner, Alexander; Savarese, Gianluigi; Wassmann, Sven; Agewall, Stefan.

In: European heart journal. Cardiovascular pharmacotherapy, 12.07.2019.

Research output: Contribution to journal › Article › peer-review

Drexel, Heinz ; Rosano, Giuseppe M C ; Lewis, Basil S ; Huber, Kurt ; Vonbank, Alexander ; Dopheide, Jörn F ; Mader, Arthur ; Niessner, Alexander ; Savarese, Gianluigi ; Wassmann, Sven ; Agewall, Stefan. / The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials. In: European heart journal. Cardiovascular pharmacotherapy. 2019.

@article{37706917fce1490892cc6dea840f5d0a,

title = "The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials",

author = "Heinz Drexel and Rosano, {Giuseppe M C} and Lewis, {Basil S} and Kurt Huber and Alexander Vonbank and Dopheide, {J{\"o}rn F} and Arthur Mader and Alexander Niessner and Gianluigi Savarese and Sven Wassmann and Stefan Agewall",

year = "2019",

month = jul,

day = "12",

doi = "10.1093/ehjcvp/pvz029",

language = "English",

journal = "European heart journal. Cardiovascular pharmacotherapy",

issn = "2055-6837",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - The age of RCT`s 3 Important Aspects of RCT`s in Cardiovascular Pharmacotherapy with examples from Lipid and Diabetes Trials

AU - Drexel, Heinz

AU - Rosano, Giuseppe M C

AU - Lewis, Basil S

AU - Huber, Kurt

AU - Vonbank, Alexander

AU - Dopheide, Jörn F

AU - Mader, Arthur

AU - Niessner, Alexander

AU - Savarese, Gianluigi

AU - Wassmann, Sven

AU - Agewall, Stefan

PY - 2019/7/12

Y1 - 2019/7/12

U2 - 10.1093/ehjcvp/pvz029

DO - 10.1093/ehjcvp/pvz029

M3 - Article

C2 - 31298686

JO - European heart journal. Cardiovascular pharmacotherapy

JF - European heart journal. Cardiovascular pharmacotherapy

SN - 2055-6837

ER -